DBV Technologies (DBVT) Enterprise Value Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,668.25% |
| Dec 31, 2025 | -498.35% |
| Sep 30, 2025 | -50.51% |
| Jun 30, 2025 | -55.86% |
| Mar 31, 2025 | 87.23% |
| Dec 31, 2024 | 77.04% |
| Sep 30, 2024 | 68.89% |
| Jun 30, 2024 | 61.94% |
| Mar 31, 2024 | 47.20% |
| Dec 31, 2023 | 32.42% |
| Sep 30, 2023 | 29.87% |
| Jun 30, 2023 | 29.85% |
| Mar 31, 2023 | -159.50% |
| Dec 31, 2022 | -170.62% |
| Sep 30, 2022 | -116.57% |
| Jun 30, 2022 | -97.59% |
| Mar 31, 2022 | 51.40% |
| Dec 31, 2021 | 60.63% |
| Sep 30, 2021 | 55.65% |
| Jun 30, 2021 | 49.55% |
| Mar 31, 2021 | 46.96% |
| Dec 31, 2020 | -3.12% |
| Sep 30, 2020 | -62.07% |
| Jun 30, 2020 | -106.41% |
| Dec 31, 2019 | -35.88% |
| Sep 30, 2019 | 14.82% |
| Jun 30, 2019 | 26.75% |
| Dec 31, 2018 | 13.68% |
| Jun 30, 2018 | 24.68% |
| Dec 31, 2017 | 41.38% |
| Jun 30, 2017 | 33.04% |
| Dec 31, 2016 | 21.88% |
| Jun 30, 2016 | -182.42% |
| Dec 31, 2015 | -147.57% |